| Patent/Application Number |
Title, Independent Claims and Summary
|
Assignee |
|
US
6641996
- Earliest priority - 09 Sep 1997
- Filed - 17 Mar 1999
- Granted - 04 Nov 2003
- Expected expiry - 08 Sep 2018
|
Title - Microbial β-glucuronidase genes, gene
products and uses thereof
Claim 1
An isolated nucleic acid molecule comprising nucleotides 1-1689 of FIGS. 4I-J
(SEQ
ID NO:14) or a nucleic acid molecule that hybridizes under stringent
conditions to the complement of nucleotides 1-1689 of FIG. 4I-J
(SEQ
ID NO:14) and which encodes a functional β-glucuronidase.
|
Claim 2
An isolated nucleic acid molecule that encodes one of the amino acid
sequences of SEQ ID NOs.: 19-21
(19,
20,
21),
or a variant thereof wherein the variant has at least 75% amino acid identity to
one of SEQ ID NOs.: 19-21 and which encodes a functional β-glucuronidase.
|
Claim 3
An expression vector comprising a nucleic acid sequence encoding a microbial
β-glucuronidase in operative linkage with a heterologous promoter, wherein the
β-glucuronidase is encoded by a nucleic acid molecule comprising nucleotides
1-1689 of FIGS. 4I-J
(SEQ
ID NO: 14) or by a nucleic acid molecule that hybridizes under stringent
conditions to the complement of nucleotides 1-1689 of FIG. 4I-J
(SEQ
ID NO:14) and which encodes a functional β-glucuronidase.
|
Claim 11
An expression vector, comprising a nucleic acid sequence encoding a microbial
β-glucuronidase in operative linkage with a heterologous promoter, wherein the
microbial β-glucuronidase comprises one of the amino acid sequences of SEQ ID
NOs.: 19-21
(19.
20,
21),
or variant thereof, wherein the variant has at least 75% amino acid identity to
one of SEQ ID NOs.: 19-21, and which encodes a functional β-glucuronidase.
|
Claim 13
A method for monitoring expression of a gene of interest or a portion thereof
in a host cell, comprising: (a) introducing into the host cell a vector
construct, the vector construct comprising a nucleic acid molecule comprising
nucleotides 1-1689 of FIGS. 4I-J
(SEQ
ID NO: 14) or by a nucleic acid molecule that hybridizes under stringent
conditions to the complement of nucleotides 1-1689 of FIG. 4I-J
(SEQ
ID NO: 14) and which encodes functional β-glucuronidase and a nucleic acid
molecule encoding a product of the gene of interest; wherein the β-glucuronidase
and the gene of interest are co-expressed; (b) detecting the presence of the
microbial β-glucuronidase, thereby monitoring expression of the gene of
interest.
|
Claim 14
A method for transforming a host cell with a gene of interest or portion
thereof, comprising: (a) introducing into the host cell a vector construct, the
vector construct comprising a nucleic acid sequence comprising nucleotides
1-1689 of FIGS. 4I-J
(SEQ
ID NO: 14) or by a nucleic acid molecule that hybridizes under stringent
conditions to the complement of nucleotides 1-1689 of FIG. 4I-J
(SEQ
ID NO:14) and which encodes a functional β-glucuronidase, and a nucleic acid
sequence encoding a product of the gene of interest, such that the vector
construct integrates into the genome of the host cell; wherein the
β-glucuronidase and the gene of interest are co-expressed; (b) detecting the
presence of the microbial β-glucuronidase, thereby establishing that the host
cell is transformed.
|
Claim 15
A method for positive selection for a transformed cell, comprising: (a)
introducing into a host cell a vector construct, the vector construct comprising
a nucleic acid sequence comprising nucleotides 1-1689 of FIGS. 4I-J
(SEQ
ID NO: 14) or by a nucleic acid molecule that hybridizes under stringent
conditions to the complement of nucleotides 1-1689 of FIG. 4I-J
(SEQ
ID NO:14) and which encodes a functional β-glucuronidase; (b) exposing the
host cell to a sample comprising a glucuronide, wherein the glucuronide is
cleaved by the β-glucuronidase, such that an aglycone is released, wherein the
aglycone is required for growth of the host cell; wherein a host cell that
expresses the β-glucuronidase grows, thereby positively selecting a transformed
cell.
|
|
Claim 17
An isolated nucleic acid molecule that encodes the amino acid sequence of
SEQ
ID NO: 22, or a variant thereof wherein the variant has at least 90% amino
acid identity to
SEQ
ID NO: 22 and which encodes a functional β-glucuronidase.
|
Claim 18
An expression vector, comprising a nucleic acid sequence encoding a microbial
β-glucuronidase in operative linkage with a heterologous promoter, wherein the
microbial β-glucuronidase comprises the amino acid sequence of
SEQ
ID NO: 22, or variant thereof, wherein the variant has at least 90% amino
acid identity to
SEQ
ID NO: 22, and which encodes a functional β-glucuronidase.
|
|
CAMBIA
|
|
US
2003/229921 A1
- Earliest priority - 09 Sep 1997
- Filed - 12 Feb 2003
- Granted - Pending
- Expected expiry - N/A
|
Title - Microbial β-glucuronidase genes, gene products and
uses thereof
Claim 1
An isolated nucleic acid molecule consisting essentially of a nucleotide
sequence that encodes a microbial β-glucuronidase, provided that the microbial
β-glucuronidase is not E. coli β-glucuronidase.
|
Claim 7
An isolated nucleic acid molecule encoding a thermostable β-glucuronidase,
wherein the β-glucuronidase has a half-life of at least 10 min at 65° C.
|
Claim 9
An isolated nucleic acid molecule encoding a microbial β-glucuronidase,
wherein the β-glucuronidase converts at least 50 nmoles of
p-nitrophenyl-glucuronide to p-nitrophenyl per minute per μg of protein at 37°
C.
|
Claim 10
An isolated nucleic acid molecule encoding a microbial β-glucuronidase,
wherein the β-glucuronidase retains at least 80% of its activity in 10 mM
glucuronic acid.
|
Claim 11
An isolated nucleic acid molecule encoding a fusion protein of a microbial
β-glucuronidase or an enzymatically active portion thereof and a second protein.
|
Claim 13
An expression vector, comprising a nucleic acid sequence encoding a microbial
β-glucuronidase in operative linkage with a heterologous promoter, provided that
the microbial β-glucuronidase is not E. coli β-glucuronidase.
|
Claim 32
An isolated form of recombinant microbial β-glucuronidase, provided that the
microbial β-glucuronidase is not E. coli β-glucuronidase.
|
Claim 38
A method for monitoring expression of a gene of interest or a portion thereof
in a host cell, comprising:
(a) introducing into the host cell a vector construct, the vector
construct comprising a nucleic acid molecule according to claim 1 and a nucleic
acid molecule encoding a product of the gene of interest or a portion thereof;
(b) detecting the presence of the microbial glucuronidase, thereby
monitoring expression of the gene of interest.
|
Claim 39
A method for transforming a host cell with a gene of interest or portion
thereof, comprising:
(a) introducing into the host cell a vector construct, the vector
construct comprising
a nucleic acid sequence encoding a microbial β-glucuronidase,
provided that the microbial β-glucuronidase is not E. coli
β-glucuronidase, and
a nucleic acid sequence encoding a product of the gene of interest or
a portion thereof, such that the vector construct integrates into the genome of
the host cell;
(b) detecting the presence of the microbial β-glucuronidase, thereby
establishing that the host cell is transformed.
|
Claim 40
A method for positive selection for a transformed cell, comprising:
(a) introducing into a host cell a vector construct, the vector construct
comprising-nucleic acid sequence encoding a microbial β-glucuronidase, provided
that the microbial β-glucuronidase is not E. coli p-glucuronidase;
(b) exposing the host cell to the sample comprising a glucuronide, wherein
the glucuronide is cleaved by the β-glucuronidase, such that the compound is
released, wherein the compound is required for cell growth.
|
Claim 43
A method of producing a transgenic plant that expresses a microbial
β-glucuronidase, comprising:
(a) introducing an expression vector comprising a nucleic acid sequence
encoding a microbial β-glucuronidase in operative linkage with a heterologous
promoter, provided that the microbial β-glucuronidase is not E. coli
β-glucuronidase, into an embryogenic plant cell; and
(b) producing a plant from the embryogenic plant cell, wherein the plant
expresses the β-glucuronidase.
|
Claim 45
A method for positive selection for a transformed cell, comprising:
(a) introducing into a host cell a vector construct, the vector construct
comprising nucleic acid sequence encoding a microbial β-glucuronidase, provided
that the microbial β-glucuronidase is not E. coli β-glucuronidase;
(b) exposing the host cell to the sample comprising a glucuronide,
wherein the glucuronide is cleaved by the β-glucuronidase, such that the
compound is released, wherein the compound is required for cell growth.
|
Claim 46
A transgenic plant cell comprising an expression vector, comprising a nucleic
acid sequence encoding a microbial β-glucuronidase in operative linkage with a
heterologous promoter, provided that the microbial β-glucuronidase is not
E. coli β-glucuronidase.
|
Claim 47
A transgenic plant comprising an expression vector, comprising a nucleic acid
sequence encoding a microbial β-glucuronidase in operative linkage with a
heterologous promoter, provided that the microbial β-glucuronidase is not
E. coli β-glucuronidase.
|
Claim 48
A transgenic aquatic animal cell comprising an expression vector, comprising
a nucleic acid sequence encoding a microbial β-glucuronidase in operative
linkage with a heterologous promoter.
|
Claim 50
A transgenic aquatic animal comprising an expression vector, comprising a
nucleic acid sequence encoding a microbial β-glucuronidase in operative linkage
with a heterologous promoter.
|
Claim 51
A method for identifying a microorganism that secretes β-glucuronidase,
comprising:
(a) culturing the microorganism in a medium containing a substrate for
β-glucuronidase, wherein the cleaved substrate is detectable, and wherein the
microorganism is an isolate of a naturally occurring microorganism or a
transgenic microorganism; and
(b) detecting the cleaved substrate in the medium; therefrom identifying an
organism that secretes β-glucuronidase.
|
Claim 54
A method for providing an effector compound to a cell in a transgenic plant,
comprising:
(a) growing a transgenic plant that comprises an expression vector,
comprising a nucleic acid sequence encoding a microbial β-glucuronidase in
operative linkage with a heterologous promoter and a nucleic acid sequence
comprising a gene encoding a cell surface receptor for an effector compound.
(b) exposing the transgenic plant to a glucuronide, wherein the glucuronide
is cleaved by the β-glucuronidase, such that the effector compound is released.
|
This application is a Continuation of
US
6641996 and the patent will soon be granted. The claim of interest
is claim 40.
|
|
AU
775238 B2
- Earliest priority - 17 Mar 1999
- Filed - 16 Mar 2000
- Granted - 22 Jul 2004
- Expected expiry - 16 Mar 2020
|
Title - Microbial β-glucuronidase genes, gene
products and uses thereof
|
Claim 1
An isolated nucleic acid molecule that encodes a microbial β-glucuronidase,
comprising nucleotides 1-1689 of Figures 4I-J (SEQ ID NO.14) or a nucleic acid
molecule that hybridizes under stringent conditions to the complement of
nucleotides 1-1689 of Figure 4I-J (SEQ ID NO.14) and which encodes a functional
β-glucuronidase.
|
|
Claim 16
An isolated form of recombinant microbial β-glucuronidase, wherein the
microbial β-glucuronidase comprises the amino acid sequence presented in Figure
3B panel E (SEQ ID NO: 6) or a variant thereof having at least 75% amino acid
sequence identity thereto.
|
|
Claim 17
A method for monitoring expression of a gene of interest or a portion thereof in
a host cell, comprising:
(a) introducing into the host cell a vector construct, the vector construct
comprising a nucleic acid molecule according to claims 1 or 2 and a nucleic acid
sequence encoding a product of the gene of interest or a portion thereof;
(b) detecting the presence of the microbial β-glucuronidase, thereby monitoring
expression of the gene of interest.
|
|
Claim 18
A method for transforming with a host cell a gene of interest or a portion
thereof, comprising:
(a) introducing into the host cell a vector construct, the vector construct
comprising a nucleic acid sequence according to claims 1 or 2 and a nucleic acid
sequence encoding a product of the gene of interest or a portion thereof such
that the vector construct integrates into the genome of the host cell; and
(b) detecting the presence of the microbial β-glucuronidase, thereby
establishing that the host cell is transformed.
|
|
Claim 19
A method for positive selection for a transformed cell, comprising:
(a) introducing into a host cell a vector construct, the vector construct
comprising nucleic acid sequence according to claims 1 or 2; and
(b) exposing the host cell to the sample comprising a glucuronide, wherein the
glucuronide is cleaved by the β-glucuronidase, such that the compound is
released, wherein the compound is required for cell growth.
|
|
Claim 22
A method of producing a transgenic plant that expresses a microbial
β-glucuronidase, comprising:
(a) introducing into an embryogenic plant cell an expression vector comprising a
nucleic acid sequence according to claims 1 or 2 in operative linkage with a
heterologous promoter; and
(b) producing a plant from the embryogenic plant cell, wherein the plant
expresses the β-glucuronidase.
|
|
Claim 28
A method for providing an effector compound to a cell of a transgenic plant,
comprising:
(a) growing a transgenic plant that comprises an expression vector, comprising
nucleic acid sequence encoding a microbial β-glucuronidase according to claims 1
or 2 in operative linkage with a heterologous promoter and a nucleic acid
sequence comprising a gene encoding a cell surface receptor for an effector
compound; and
(b) exposing the transgenic plant to a glucuronide, wherein the glucuronide in
cleaved by the β-glucuronidase, such that the effector compound is released.
|
Another related patent with claims to use of a β-glucuronidase in positive
selection has issued in Australia
(760275).
|
|
Remarks
|
Related patent applications were also filed in Europe (EP 1175495
A1), New Zealand (NZ 503020), Japan (JP
2001515724) and Canada (CA 2303423). A related patent
(application published as
WO
2000/055333) has been issued in New Zealand as Patent Number 1485.
A related patent (application published as
WO
1999/13085) has been issued in the US
(7087420)
and is pending in Australia, Canada, Europe and further applications are pending
in the United States as application numbers 10/120, 145 and 10/364, 649 (both
recently allowed and soon to issue) in Brazil, Canada, Europe and Israel.
A patent on producing a substrate for glucuronidase positive selection issued
in the United States as Patent Number
6268493
is shown in the table below.
|
There are no comments.